Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 223 of 5804
-
New study tests targeted pill combo for advanced breast cancer in Real-World settings
Disease control Recruiting nowGiven that pyrotinib has been proven to exert significant efficacy against HER2-positive advanced breast cancer in multiple Phase III studies, and the novel ADC drug disitamab vedotin has demonstrated potent anti-tumor activity, there remains insufficient real-world data on their…
Phase: PHASE4 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Brain wave alert: new tool could predict delirium hours before it strikes after heart surgery
Knowledge-focused Not yet recruitingAfter heart surgery, up to half of all patients may develop a state of sudden confusion called postoperative delirium. This condition can lead to longer time on a breathing machine, extended stays in the intensive care unit (ICU), and a slower overall recovery. Currently, doctors…
Sponsor: Southeast University, China • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Probiotic pill aims to stop recurrent cystitis without antibiotics
Prevention Not yet recruitingRecurrent cystitis is a common condition in menopausal women and is associated with impaired quality of life and increased antibiotic use. This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the efficacy and safety of Colipral® in preventing recurren…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Prevention
Last updated Jul 08, 2026 00:00 UTC
-
New diabetes pill elecoglipron faces final test in 600-Patient trial
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with placebo in adults with Type 2 Diabetes Mellitus (T2DM), treated with a background insulin and other background glucose-lowering medication(s)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for young leukemia patients: experimental drug combo targets resistant cancer
Disease control Recruiting nowMulti-center, open-label, single arm study of asciminib in participants aged ≥1 year to ≤30 years old with r/r Ph+ or ABL-class Ph-like ALL. This study will have 2 parts: Part 1 dose escalation and Part 2 dose expansion. Part 1 dose escalation will enroll participants aged ≥1 yea…
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
A simple blood draw could detect bladder Cancer's return — a trial puts it to the test
Knowledge-focused Recruiting nowThis study investigates the feasibility of the Labcorp Plasma Detect, which is an assay (test) that looks for circulating tumor DNA (ctDNA) in patients who have muscle-invasive (MI) urothelial carcinoma (also known as MI bladder cancer, MIBC). During this study, tissue, blood and…
Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Laser and AI team up to spot lung cancer in minutes during surgery
Diagnosis Recruiting nowThis study aims to evaluate whether femtosecond laser imaging combined with FastLung AI model can provide intraoperative diagnostic performance that is non-inferior to standard frozen section diagnosis for pulmonary nodules or suspected pulmonary tumor lesions. Patients scheduled…
Sponsor: Shanghai Chest Hospital • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Could an immune drug ease schizophrenia symptoms?
Disease control Recruiting nowThe main objective of this Phase 2 study is to assess the efficacy of ublituximab as measured by positive and negative syndrome scale (PANSS) total score in participants with schizophrenia.
Phase: PHASE2 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Targeted antibody may boost brain cancer treatment after incomplete surgery
Disease control Not yet recruitingThis is a prospective, single-arm study. The study population consists of adult patients with a confirmed diagnosis of EGFR-positive high-grade glioma who have radiographic residual tumor following surgical resection. Participants will receive nimotuzumab in combination with the …
Phase: PHASE2 • Sponsor: Tianjin First Central Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Extra ablation target may cut AF recurrence in persistent cases
Disease control ENROLLING_BY_INVITATIONTo date, no optimal treatment has been established to improve outcomes in patients with persistent atrial fibrillation. The safety and efficacy of pulsed-field ablation (PFA) have been demonstrated in several studies, and its clinical application is expanding. \- In patients wit…
Phase: NA • Sponsor: Ewha Womans University Mokdong Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New 'Smart' immune cells take on kidney cancer in early trial
Disease control Recruiting nowThere are 2 parts to this clinical research study: Part 1 (Dose Escalation) and Part 2 (Dose Expansion). The goal of Part 1 is to find the recommended dose of LNK001 in patients with advanced or metastatic ccRCC. The goal of Part 2 is to learn if the recommended dose of LNK001 …
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Targeted radiation zaps childhood brain tumors in early trial
Disease control Recruiting nowThe purpose of this study is to find out whether 177Lu-DPTA-omburtamab is a safe treatment for children and adolescents with recurrent/refractory medulloblastoma or another type of cancer with CNS metastases.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for kids with resistant cancers: targeted drug enters trial
Disease control Recruiting nowResearchers are looking for new ways to treat children with relapsed or refractory solid tumors: * Relapsed means the cancer came back after treatment * Refractory means the cancer did not respond (get smaller or go away) to treatment * Solid tumors are cancers mostly in body or…
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Patient feedback after surgery may cut opioid misuse by half
Disease control Not yet recruitingThe OPTIMISTE program is based on a structured postoperative follow-up centered on patients' subjective perception of recovery using validated Patient Reported Outcome Measures (PROMs), including the mQoR-15f score. Follow-up is delivered by specifically trained nurses and embedd…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New shot aims to help kids with rare heart-muscle disease move easier
Disease control Recruiting nowPhase 3b/4, randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the efficacy, safety, and pharmacokinetics of a once daily SC injection of elamipretide in subjects with genetically confirmed BTHS for 72 weeks. The primary trial objective is to …
Phase: PHASE4 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Eye scans could spot deadly heart disease before symptoms appear
Diagnosis Not yet recruitingThis multicenter pilot study will enroll adult participants with a confirmed clinical diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) and heart failure (HF) controls with documentation within the past 2 years that either excludes ATTR-CM or indicates a low probability…
Sponsor: AstraZeneca • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
Viruses that eat bacteria could help save infected joint replacements
Disease control Not yet recruitingTotal joint replacement (TJR) has revolutionized care provided for patients suffering from disabling joint pain. Unfortunately, periprosthetic joint infection (PJI) remains a devastating complication and the leading cause of failure after TJR. Current standard treatment for PJI r…
Phase: PHASE2, PHASE3 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New ultrasound technique could reveal hidden blood vessels in liver tumors
Diagnosis Not yet recruitingThe macroscopic vascular supply of liver tumors varies considerably according to histological subtype, lesion size, and disease stage. Current clinical imaging modalities primarily characterize liver tumors based on their macroscopic vascular perfusion patterns. Conventional colo…
Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
New combo aims to shrink bladder tumors without chemo
Disease control Not yet recruitingThe researchers are doing this study to find out whether stereotactic body radiation therapy (SBRT) in combination with immunotherapy (cemiplimab with or without fianlimab) before cystectomy is an effective and safe treatment for people with muscle-invasive bladder cancer (MIBC).
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New proton therapy trial aims to reduce side effects in nasopharyngeal cancer
Disease control Not yet recruitingProton therapy for nasopharyngeal carcinoma can reduce radiotherapy-related toxic reactions, and some retrospective studies have found that proton therapy improves the survival of patients with nasopharyngeal carcinoma. However, high-level prospective clinical evidence is still l…
Phase: NA • Sponsor: Guangzhou Concord Cancer Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC